In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

Journal of Medical Virology

Volumn 84, Issue 8, 2012, Pages 1166-1176

  Cabuang, Liza M ^a   Shaw, Tim ^a   Littlejohn, Margaret ^a   Colledge, Danni ^a   Sozzi, Vitini ^a   Soppe, Sally ^a   Warner, Nadia ^a   Thompson, Alex ^a,b   Preiss, Scott ^a,i   Lam, Natasha ^a,c   Walsh, Renae ^a   Lewin, Sharon R ^d,e,h   Thio, Chloe L ^f   Matthews, Gail ^g   Locarnini, Stephen A ^a   Revill, Peter A ^a,c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Infectious Diseases Unit   (Australia)

^e BURNET INSTITUTE   (Australia)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g ST VINCENT S HOSPITAL   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Co infection, precore, HBeAg, virus replication, ER stress; HBV; HIV

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; GOLGI COMPLEX; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; MIXED INFECTION; NONHUMAN; PHENOTYPE; PROTEIN SYNTHESIS; VIRION; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE, TUMOR; COINFECTION; DNA, VIRAL; GENETIC VARIATION; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; MUTATION; PHENOTYPE; VIRUS REPLICATION;

EID: 84862654949     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23328     Document Type: Article

References (30)

1. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2: 326-332.
2. Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C. 1997. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113: 1976-1982.
3. Chen RY, Edwards R, Shaw T, Colledge D, Delaney WET, Isom H, Bowden S, Desmond P, Locarnini SA. 2003. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology 37: 27-35.
4. Chin R, Shaw T, Torresi J, Sozzi V, Trautwein C, Bock T, Manns M, Isom H, Furman P, Locarnini S. 2001. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2, 6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Antimicrob Agents Chemother 45: 2495-2501.
5. Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C. 2005. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79: 13483-13496.
6. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, Benhamou JP, Erlinger S, Valla D, Marcellin P. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29: 1306-1310.
7. Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G, Luo KX, Paik SW, Liaw YF, Button P, Popescu M. 2008. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology 47: 428-434.
8. Fukushima K, Ueno Y, Inoue J, Wakui Y, Obara N, Kimura O, Kido O, Nakagome Y, Kakazu E, Matsuda Y, Kogure T, Kondo Y, Nagasaki F, Yamagiwa Y, Ashino Y, Shimosegawa T. 2008. A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir. Hepatol Res 38: 842-846.
9. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IV. 1997. Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS 11: 597-606.
10. Gunther S, Piwon N, Jung A, Iwanska A, Schmitz H, Will H. 2000. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 273: 286-299.
11. Hadziyannis SJ. 1995. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment. Viral Hepat Rev 101: 7-36.
12. Iser DM, Warner N, Revill PA, Solomon A, Wightman F, Saleh S, Crane M, Cameron PU, Bowden S, Nguyen T, Pereira CF, Desmond PV, Locarnini SA, Lewin SR. 2010. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. J Virol 84: 5860-5867.
13. Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. 2011. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol 55: 762-769.
14. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
15. Leemans WF, Janssen HL, de Man RA. 2007. Future prospectives for the management of chronic hepatitis B. World J Gastroenterol 13: 2554-2567.
16. Lindh M, Savage K, Rees J, Garwood L, Horal P, Norkrans G, Dhillon AP. 1999. HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. Liver 19: 294-298.
17. Lok AS, McMahon BJ. 2009. Chronic hepatitis B: Update 2009. Hepatology 50: 661-662.
18. Marschenz S, Endres AS, Brinckmann A, Heise T, Kristiansen G, Nurnberg P, Kruger DH, Gunther S, Meisel H. 2006. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 131: 765-780.
19. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87: 6599-6603.
20. Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA. 2007. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS 21: 1701-1710.
21. Revill P, Yuen L, Walsh R, Perrault M, Locarnini S, Kramvis A. 2010. Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. J Med Virol 82: 104-115.
22. Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM. 1984. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 101: 795-797.
23. Scaglioni PP, Melegari M, Wands JR. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol 71: 345-353.
24. Skelton M, Kew MC, Kramvis A. 2012. Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. Virus Res 163: 59-65.
25. Thio CL, Seaberg EC, Skolasky R, Jr., Phair J, Visscher B, Munoz A, Thomas DL. 2002. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
26. Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45: 102-110.
27. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ. 2003. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163: 2441-2449.
28. Warner N, Locarnini S. 2008. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48: 88-98.
29. Wilson R, Warner N, Ryan K, Selleck L, Colledge D, Rodgers S, Li K, Revill P, Locarnini S. 2011. The hepatitis B e antigen suppresses IL-1beta-mediated NF-kappaB activation in hepatocytes. J Viral Hepat 18: 499-507.
30. Zhang K, Wong HN, Song B, Miller CN, Scheuner D, Kaufman RJ. 2005. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest 115: 268-281.